AzTrials
AzTrials

BronchiectasisPhase 3NCT07915219

A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)

A Phase 3 study testing verducatib in people with Bronchiectasis, run by Boehringer Ingelheim at 383 sites in 39 countries.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This study is for adults and adolescents who are at least 12 years old and have bronchiectasis. People can participate if they completed a previous study with the study medicine called verducatib. Read more about this study

Who is it for?
Ages 12 years and older
Conditions the study is for
Bronchiectasis
What is being tested?
verducatib
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,500 participants
Where
383 sitesin 39 countries
Study dates
11 Jan 2027to 10 Sep 2029
Phase
Phase 3
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 years and older
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Participants (adults and adolescents ≥12 years of age) who completed the treatment period in trials 1397-0014 or 1397-0017 as planned per protocol and did not discontinue trial treatment prematurely.
  • Male or female participants. Women of childbearing potential (WOCBP) must be ready and able to use highly effective methods of birth control per International Council of Harmonisation (ICH) M3 (R2) that result in a low failure rate of less than 1% per year when used consistently and correctly. A list of contraception methods meeting these criteria is provided in the participant information.
  • Signed and dated written informed consent and assent, if applicable, prior to admission to the trial, in accordance with Good Clinical Practice (GCP) and local legislation.

Who cannot join

  • Moderate or severe liver disease (defined by Child-Pugh score B or C hepatic impairment), unless the investigator determines it is in the best interest of the participant to enrol in the trial.
  • Estimated glomerular filtration rate (eGFR) according to Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula (adults) and Chronic Kidney Disease Under 25 (CKiD-U25) (adolescents) <30 mL/min at Visit 1 (or at the last safety assessment in the parent trial, if no more than 6 weeks passed since then), unless the investigator determines it is in the best interest of the participant to enrol in the trial.
  • An absolute blood neutrophil count <1000/mm^3 (equivalent to <1000 cells/µL or <10^9 cells/L) at Visit 1 (or at the last safety assessment in the parent trial, if no more than 6 weeks passed since then).
  • Any findings in the medical examination and/or laboratory value assessed at Visit 1 (or at the last safety assessment in the parent trial, concerning the laboratory tests, if no more than 6 weeks passed since then), that in the opinion of the investigator may put the participant at risk by participating in the trial.
  • Diagnosis of primary or secondary immunodeficiency made after end of treatment in preceding trial.
  • Any relevant pulmonary, gastrointestinal, hepatic, renal, cardiovascular, metabolic, immunological, hormonal, or other disorder that, in the opinion of the investigator, may put the participant at risk by participating in the study.
Show all 9Show fewer
  • Participants who must or wish to continue the intake of restricted medications or any drug considered likely to interfere with the safe conduct of the trial.
  • Participants not expected to comply with the protocol requirements or not expected to complete the trial as scheduled, i.e. chronic alcohol or drug abuse or any other condition that, in the investigator's opinion, makes the participant an unreliable trial participant.
  • Further exclusion criteria apply.

Trial locations and contacts

383 sites in 39 countries. Contact the study team or a site near you to ask about taking part.

Boehringer Ingelheim contact

18002430127

clintriage.rdg@boehringer-ingelheim.com

383 sites in 39 countries

United States48 sites

  • University of Michigan

    Ann Arbor, Michigan, 48109

    Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com

  • Augusta University

    Augusta, Georgia, 30912

    Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com

  • Meris Clinical Research-Brandon-69466

    Brandon, Florida, 33511

    Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com

  • Medical University of South Carolina

    Charleston, South Carolina, 29425

    Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com

  • University of Cincinnati

    Cincinnati, Ohio, 45267

    Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com

  • University Hospitals Cleveland Medical Center

    Cleveland, Ohio, 44106

    Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com

  • University of Vermont

    Colchester, Vermont, 05446

    Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com

  • Horizon Clinical Research Group

    Cypress, Texas, 77429

    Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com

  • Baylor University Medical Center

    Dallas, Texas, 75246

    Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com

  • University of Texas Southwestern Medical Center

    Dallas, Texas, 75390

    Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com

  • National Jewish Health

    Denver, Colorado, 80206

    Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com

  • Clinical Research Associates of Central PA

    DuBois, Pennsylvania, 15801

    Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com

  • El Paso Pulmonary Association

    El Paso, Texas, 79902

    Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com

  • Inova Fairfax Medical Campus

    Falls Church, Virginia, 22042

    Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com

  • University of Texas Medical Branch at Galveston

    Galveston, Texas, 77555

    Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com

  • New York Medical College - Hawthorne

    Hawthorne, New York, 10532

    Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com

  • Baylor College of Medicine

    Houston, Texas, 77030

    Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com

  • Stern Research Partners, LLC

    Huntersville, North Carolina, 28078

    Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com

  • University of Florida College of Medicine

    Jacksonville, Florida, 32209

    Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com

  • Mayo Clinic - Florida

    Jacksonville, Florida, 32224

    Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com

  • University of Kansas Medical Center

    Kansas City, Kansas, 66160

    Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com

  • University of Wisconsin

    Madison, Wisconsin, 53792

    Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com

  • Metroplex Pulmonary & Sleep Center

    McKinney, Texas, 75069

    Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com

  • Intermountain Healthcare

    Murray, Utah, 84107-4107

    Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com

  • Essence MD Research

    Naples, Florida, 34102

    Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com

  • Northwell Health

    New Hyde Park, New York, 11040

    Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com

  • New York University Langone Medical Center

    New York, New York, 10017

    Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com

  • Icahn School of Medicine at Mount Sinai

    New York, New York, 10029

    Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com

  • New York Presbyterian Hospital -Columbia University

    New York, New York, 10032

    Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com

  • Newport Native MD, Inc

    Newport Beach, California, 92663

    Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com

  • University of Nebraska Medical Center

    Omaha, Nebraska, 68198-5910

    Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com

  • University of Pennsylvania

    Philadelphia, Pennsylvania, 19104

    Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com

  • Jefferson Health Honickman Center

    Philadelphia, Pennsylvania, 19107

    Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com

  • Pinehurst Medical Clinic, Inc. - East

    Pinehurst, North Carolina, 28374

    Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com

  • Paradigm Clinical Research - Redding

    Redding, California, 96001

    Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com

  • Virginia Commonwealth University Health Systems

    Richmond, Virginia, 23219

    Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com

  • Mayo Clinic, Rochester

    Rochester, Minnesota, 55905

    Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com

  • Clinical Research of Rock Hill

    Rock Hill, South Carolina, 29732

    Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com

  • University of California Davis

    Sacramento, California, 95817

    Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com

  • HealthPartners Specialty Center 401 Building

    Saint Paul, Minnesota, 55130

    Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com

  • IMA Clinical Research San Antonio

    San Antonio, Texas, 78229

    Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com

  • University of Washington

    Seattle, Washington, 98195

    Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com

  • Providence Medical Research Center

    Spokane, Washington, 99204

    Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com

  • Washington University School of Medicine

    St Louis, Missouri, 63110

    Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com

  • Vantage Clinical Trials - Tampa

    Tampa, Florida, 33614

    Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com

  • University of Arizona

    Tucson, Arizona, 85724

    Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com

  • University of Texas Health Science Center at Tyler

    Tyler, Texas, 75708

    Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com

  • Cleveland Clinic Florida

    Weston, Florida, 33331

    Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com

Other trials in United States

China48 sites

  • China-Japan Friendship Hospital

    Beijing, 100029

    Boehringer Ingelheim, 4001200553, china@bitrialsupport.com

  • Beijing Children's Hospital, Capital Medical University

    Beijing, 100045

    Boehringer Ingelheim, 4001200553, china@bitrialsupport.com

  • Peking University Third Hospital

    Beijing, 100191

    Boehringer Ingelheim, 4001200553, china@bitrialsupport.com

  • Peking Union Medical College Hospital

    Beijing, 100730

    Boehringer Ingelheim, 4001200553, china@bitrialsupport.com

  • The First Hospital of Jilin University

    Changchun, 130000

    Boehringer Ingelheim, 4001200553, china@bitrialsupport.com

  • The Second Hospital of Jilin University

    Changchun, 130000

    Boehringer Ingelheim, 4001200553, china@bitrialsupport.com

  • The Second Xiangya Hospital Of Central South University

    Changsha, 410011

    Boehringer Ingelheim, 4001200553, china@bitrialsupport.com

  • West China Hospital, Sichuan University

    Chengdu, 610041

    Boehringer Ingelheim, 4001200553, china@bitrialsupport.com

  • First Affiliated Hospital of Guangzhou Medical University

    Guangzhou, 510000

    Boehringer Ingelheim, 4001200553, china@bitrialsupport.com

  • Guangdong Provincial People's Hospital

    Guangzhou, 510080

    Boehringer Ingelheim, 4001200553, china@bitrialsupport.com

  • Guizhou Provincial People's Hospital

    Guiyang, 550002

    Boehringer Ingelheim, 4001200553, china@bitrialsupport.com

  • Hangzhou First People's Hospital

    Hangzhou, 310006

    Boehringer Ingelheim, 4001200553, china@bitrialsupport.com

  • The Second Affiliated Hospital Zhejiang University School of Medicine

    Hangzhou, 310009

    Boehringer Ingelheim, 4001200553, china@bitrialsupport.com

  • Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine

    Hangzhou, 310016

    Boehringer Ingelheim, 4001200553, china@bitrialsupport.com

  • Zhejiang Hospital

    Hangzhou, 310030

    Boehringer Ingelheim, 4001200553, china@bitrialsupport.com

  • The First Affiliated Hospital of Anhui Medical University

    Hefei, 230022

    Boehringer Ingelheim, 4001200553, china@bitrialsupport.com

  • Huzhou Central Hospital

    Huzhou, 313000

    Boehringer Ingelheim, 4001200553, china@bitrialsupport.com

  • Jiangmen Central Hospital

    Jiangmen, 529030

    Boehringer Ingelheim, 4001200553, china@bitrialsupport.com

  • The First Affiliated Hospital of Nanchang University

    Nanchang, 330000

    Boehringer Ingelheim, 4001200553, china@bitrialsupport.com

  • The Second Affiliated Hospital to Nanchang University

    Nanchang, 330006

    Boehringer Ingelheim, 4001200553, china@bitrialsupport.com

  • Nanjing First Hospital

    Nanjing, 210006

    Boehringer Ingelheim, 4001200553, china@bitrialsupport.com

  • Nanjing Drum Tower Hospital

    Nanjing, 210008

    Boehringer Ingelheim, 4001200553, china@bitrialsupport.com

  • Affiliated Hospital of Nantong University

    Nantong, 226001

    Boehringer Ingelheim, 4001200553, china@bitrialsupport.com

  • Ningbo Medical Center Lihuili Hospital

    Ningbo, 315000

    Boehringer Ingelheim, 4001200553, china@bitrialsupport.com

  • The First Affiliated Hospital of Ningbo University

    Ningbo, 315010

    Boehringer Ingelheim, 4001200553, china@bitrialsupport.com

  • Pingxiang People's Hospital

    Pingxiang, 337000

    Boehringer Ingelheim, 4001200553, china@bitrialsupport.com

  • Qingdao Municipal Hospital

    Qingdao, 266011

    Boehringer Ingelheim, 4001200553, china@bitrialsupport.com

  • The Second Affiliated Hospital of Fujian Medical University

    Quanzhou, 362000

    Boehringer Ingelheim, 4001200553, china@bitrialsupport.com

  • Ruijin Hospital Shanghai Jiao Tong University School of Medicine

    Shanghai, 200025

    Boehringer Ingelheim, 4001200553, china@bitrialsupport.com

  • Zhongshan Hospital Affiliated to Fudan University

    Shanghai, 200032

    Boehringer Ingelheim, 4001200553, china@bitrialsupport.com

  • Huadong Hospital affiliated to Fudan University

    Shanghai, 200040

    Boehringer Ingelheim, 4001200553, china@bitrialsupport.com

  • Shanghai General Hospital

    Shanghai, 200080

    Boehringer Ingelheim, 4001200553, china@bitrialsupport.com

  • Shanghai Fifth People's Hospital affiliated to Fudan University

    Shanghai, 200240

    Boehringer Ingelheim, 4001200553, china@bitrialsupport.com

  • Shanghai Pulmonary Hospital

    Shanghai, 200433

    Boehringer Ingelheim, 4001200553, china@bitrialsupport.com

  • The Children's Hospital of Fudan University

    Shanghai, 201102

    Boehringer Ingelheim, 4001200553, china@bitrialsupport.com

  • Qingpu Branch of Zhongshan Hospital Affiliated to Fudan University

    Shanghai, 201700

    Boehringer Ingelheim, 4001200553, china@bitrialsupport.com

  • Shenzhen People's Hospital

    Shenzhen, 518020

    Boehringer Ingelheim, 4001200553, china@bitrialsupport.com

  • The First Affiliated Hospital of Soochow University

    Suzhou, 215006

    Boehringer Ingelheim, 4001200553, china@bitrialsupport.com

  • Tianjin Medical University General Hospital

    Tianjin, 300052

    Boehringer Ingelheim, 4001200553, china@bitrialsupport.com

  • The First Affiliated Hospital of Wenzhou Medical University

    Wenzhou, 325000

    Boehringer Ingelheim, 4001200553, china@bitrialsupport.com

  • Wenzhou People's Hospital

    Wenzhou, 325006

    Boehringer Ingelheim, 4001200553, china@bitrialsupport.com

  • Union Hospital Tongji Medical College Huazhong University of Science and Technology

    Wuhan, 430022

    Boehringer Ingelheim, 4001200553, china@bitrialsupport.com

  • Tongji Hospital Affiliated Tongji Medical College Huazhong University of S & T

    Wuhan, 430030

    Boehringer Ingelheim, 4001200553, china@bitrialsupport.com

  • Wuxi People's Hospital

    Wuxi, 214043

    Boehringer Ingelheim, 4001200553, china@bitrialsupport.com

  • First Affiliated Hospital of Xi'an JiaoTong University

    Xi'an, 710061

    Boehringer Ingelheim, 4001200553, china@bitrialsupport.com

  • The Affiliated Hospital of Xuzhou Medical College

    Xuzhou, 221006

    Boehringer Ingelheim, 4001200553, china@bitrialsupport.com

  • Northern Jiangsu People's Hospital

    Yangzhou, 225001

    Boehringer Ingelheim, 4001200553, china@bitrialsupport.com

  • Yixing People'S Hospital

    Yixing, 214258

    Boehringer Ingelheim, 4001200553, china@bitrialsupport.com

Other trials in China

Japan35 sites

  • Nagoya University Hospital

    Aichi, Nagoya, 466-8560

    Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com

  • Hirosaki University Hospital

    Aomori, Hirosaki, 036-8563

    Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com

  • Chiba University Hospital

    Chiba, Chiba, 260-8677

    Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com

  • Kameda Clinic

    Chiba, Kamogawa, 296-0041

    Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com

  • Kyushu University Hospital

    Fukuoka, Fukuoka, 812-8582

    Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com

  • Fukuoka University Hospital

    Fukuoka, Fukuoka, 814-0180

    Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com

  • Terada Clinic, Respiratory Medicine & General practice

    Hyogo, Himeji, 670-0849

    Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com

  • Ibarakihigashi National Hospial

    Ibaraki, Naka-gun, 319-1113

    Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com

  • University of Tsukuba Hospital

    Ibaraki, Tsukuba, 305-8576

    Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com

  • Kagoshima University Hospital

    Kagoshima, Kagoshima, 890-8520

    Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com

  • Kanagawa Cardiovascular and Respiratory Center

    Kanagawa, Yokohama, 236-0051

    Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com

  • Minami Kyoto Hospital

    Kyoto, Joyo, 610-0113

    Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com

  • Kyoto University Hospital

    Kyoto, Kyoto, 606-8507

    Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com

  • Matsusaka City Hospital

    Mie, Matsusaka, 515-8544

    Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com

  • Tohoku University Hospital

    Miyagi, Sendai, 980-8574

    Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com

  • Nagasaki University Hospital

    Nagasaki, Nagasaki, 852-8501

    Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com

  • Niigata University Medical and Dental Hospital

    Niigata, Niigata, 951-8520

    Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com

  • Oita University Hospital

    Oita, Yufu, 879-5593

    Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com

  • Kurashiki Central Hospital

    Okayama, Kurashiki, 710-8602

    Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com

  • National Hospital Organization Kinki-Chuo Chest Medical Center

    Osaka, Sakai, 591-8555

    Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com

  • Osaka Toneyama Medical Center

    Osaka, Toyonaka, 560-8552

    Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com

  • Saga University Hospital

    Saga, Saga, 849-8501

    Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com

  • Saitama Cardiovascular and Respiratory Center

    Saitama, Kumagaya, 360-0197

    Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com

  • Shiga University of Medical Science Hospital

    Shiga, Otsu, 520-2192

    Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com

  • Matsue Medical Center

    Shimane, Matsue, 690-8556

    Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com

  • Hamamatsu University Hospital

    Shizuoka, Hamamatsu, 431-3192

    Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com

  • Tenryu Hospital

    Shizuoka, Hamamatsu, 434-8511

    Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com

  • Tokushima University Hospital

    Tokushima, Tokushima, 770-8503

    Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com

  • Institute of Science Tokyo Hospital

    Tokyo, Bunkyo-ku, 113-8519

    Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com

  • Nihon University Itabashi Hospital

    Tokyo, Itabashi-ku, 173-8610

    Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com

  • Fukujuji Hospital

    Tokyo, Kiyose, 204-8522

    Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com

  • Toranomon Hospital

    Tokyo, Minato-ku, 105-8470

    Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com

  • Keio University Hospital

    Tokyo, Shinjuku-ku, 160-8582

    Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com

  • Tokyo Women's Medical University Hospital

    Tokyo, Shinjuku-ku, 162-8666

    Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com

  • Yamaguchi University Hospital

    Yamaguchi, Ube, 755-8505

    Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com

Other trials in Japan

Germany31 sites

  • Universitätsklinikum Aachen, AöR

    Aachen, 52074

    Boehringer Ingelheim, 08007234742, deutschland@bitrialsupport.com

  • Velocity Clinical Research Germany GmbH, Ahrensburg

    Ahrensburg, 22926

    Boehringer Ingelheim, 08007234742, deutschland@bitrialsupport.com

  • CIMS Studienzentrum Bamberg GmbH

    Bamberg, 96049

    Boehringer Ingelheim, 08007234742, deutschland@bitrialsupport.com

  • Charité - Universitätsmedizin Berlin

    Berlin, 10117

    Boehringer Ingelheim, 08007234742, deutschland@bitrialsupport.com

  • Vivantes Netzwerk für Gesundheit GmbH

    Berlin, 12351

    Boehringer Ingelheim, 08007234742, deutschland@bitrialsupport.com

  • Charité - Universitätsmedizin Berlin

    Berlin, 13353

    Boehringer Ingelheim, 08007234742, deutschland@bitrialsupport.com

  • Katholisches Klinikum Bochum gGmbH

    Bochum, 44791

    Boehringer Ingelheim, 08007234742, deutschland@bitrialsupport.com

  • Universitätsklinikum Bonn AöR

    Bonn, 53127

    Boehringer Ingelheim, 08007234742, deutschland@bitrialsupport.com

  • Augustiner Krankenhäuser GmbH

    Cologne, 50678

    Boehringer Ingelheim, 08007234742, deutschland@bitrialsupport.com

  • Universitätsklinikum Köln (AöR)

    Cologne, 50937

    Boehringer Ingelheim, 08007234742, deutschland@bitrialsupport.com

  • Caritas-Krankenhaus St. Maria gGmbH

    Donaustauf, 93093

    Boehringer Ingelheim, 08007234742, deutschland@bitrialsupport.com

  • Klinikum Dortmund gGmbH

    Dortmund, 44145

    Boehringer Ingelheim, 08007234742, deutschland@bitrialsupport.com

  • Technische Universität Dresden

    Dresden, 01307

    Boehringer Ingelheim, 08007234742, deutschland@bitrialsupport.com

  • Ruhrlandklinik, Westdeutsches Lungenzentrum am Universitätsklinikum Essen gGmbH

    Essen, 45239

    Boehringer Ingelheim, 08007234742, deutschland@bitrialsupport.com

  • Universitätsklinikum Frankfurt

    Frankfurt, 60590

    Boehringer Ingelheim, 08007234742, deutschland@bitrialsupport.com

  • IKF Pneumologie GmbH & Co. KG

    Frankfurt, 60596

    Boehringer Ingelheim, 08007234742, deutschland@bitrialsupport.com

  • Universitätsklinikum Freiburg

    Freiburg im Breisgau, 79106

    Boehringer Ingelheim, 08007234742, deutschland@bitrialsupport.com

  • Asklepios Fachkliniken München-Gauting

    Gauting, 82131

    Boehringer Ingelheim, 08007234742, deutschland@bitrialsupport.com

  • Martin-Luther-Universität Halle-Wittenberg

    Halle, 06120

    Boehringer Ingelheim, 08007234742, deutschland@bitrialsupport.com

  • Medizinische Hochschule Hannover

    Hanover, 30625

    Boehringer Ingelheim, 08007234742, deutschland@bitrialsupport.com

  • Thoraxklinik-Heidelberg gGmbH am Universitätsklinikum Heidelberg

    Heidelberg, 69126

    Boehringer Ingelheim, 08007234742, deutschland@bitrialsupport.com

  • Universitätsklinikum Jena

    Jena, 07747

    Boehringer Ingelheim, 08007234742, deutschland@bitrialsupport.com

  • Universitätsklinikum Schleswig-Holstein, Campus Kiel

    Kiel, 24105

    Boehringer Ingelheim, 08007234742, deutschland@bitrialsupport.com

  • Velocity Clinical Research Germany GmbH

    Lübeck, 23552

    Boehringer Ingelheim, 08007234742, deutschland@bitrialsupport.com

  • Universitätsmedizin der Johannes Gutenberg-Universität Mainz

    Mainz, 55131

    Boehringer Ingelheim, 08007234742, deutschland@bitrialsupport.com

  • Klinikum der Universität München AÖR

    München, 80336

    Boehringer Ingelheim, 08007234742, deutschland@bitrialsupport.com

  • Pneumologisches Studienzentrum München-West

    München, 81241

    Boehringer Ingelheim, 08007234742, deutschland@bitrialsupport.com

  • Universitätsklinikum Münster

    Münster, 48149

    Boehringer Ingelheim, 08007234742, deutschland@bitrialsupport.com

  • Klinikum Ernst von Bergmann GmbH, CF-Zentrum Potsdam

    Potsdam, 14467

    Boehringer Ingelheim, 08007234742, deutschland@bitrialsupport.com

  • Helios Hanseklinikum Stralsund

    Stralstund, 18435

    Boehringer Ingelheim, 08007234742, deutschland@bitrialsupport.com

  • BAG Wiesbaden

    Wiesbaden, 65183

    Boehringer Ingelheim, 08007234742, deutschland@bitrialsupport.com

Other trials in Germany

Spain21 sites

  • Complejo Hospitalario Universitario A Coruña

    A Coruña, 15006

    Boehringer Ingelheim, 900876092, espana@bitrialsupport.com

  • Hospital Germans Trias i Pujol

    Badalona, 08916

    Boehringer Ingelheim, 900876092, espana@bitrialsupport.com

  • Hospital Universitari Vall d'Hebron

    Barcelona, 08035

    Boehringer Ingelheim, 900876092, espana@bitrialsupport.com

  • Hospital Clínic de Barcelona

    Barcelona, 08036

    Boehringer Ingelheim, 900876092, espana@bitrialsupport.com

  • Hospital Universitario Virgen de la Arrixaca

    El Palmar, 30120

    Boehringer Ingelheim, 900876092, espana@bitrialsupport.com

  • Hospital Universitari de Girona Doctor Josep Trueta

    Girona, 17007

    Boehringer Ingelheim, 900876092, espana@bitrialsupport.com

  • Hospital Juan Ramón Jimenez

    Huelva, 21005

    Boehringer Ingelheim, 900876092, espana@bitrialsupport.com

  • Hospital Infanta Elena

    Huelva, 21080

    Boehringer Ingelheim, 900876092, espana@bitrialsupport.com

  • Hospital Jerez de la Frontera

    Jerez de la Frontera, 11407

    Boehringer Ingelheim, 900876092, espana@bitrialsupport.com

  • Hospital Universitari de Bellvitge

    L'Hospitalet Del Llobregat, 08907

    Boehringer Ingelheim, 900876092, espana@bitrialsupport.com

  • Hospital Universitario La Paz

    Madrid, 28046

    Boehringer Ingelheim, 900876092, espana@bitrialsupport.com

  • Hospital de Mérida

    Mérida, 06800

    Boehringer Ingelheim, 900876092, espana@bitrialsupport.com

  • Hospital Central de Asturias

    Oviedo, 33011

    Boehringer Ingelheim, 900876092, espana@bitrialsupport.com

  • Hospital Son Espases

    Palma de Mallorca, 07120

    Boehringer Ingelheim, 900876092, espana@bitrialsupport.com

  • Hospital Universitario de Navarra

    Pamplona, 31008

    Boehringer Ingelheim, 900876092, espana@bitrialsupport.com

  • Hospital Memorial Publio Cordon

    Pozuelo de Alarcón, 28223

    Boehringer Ingelheim, 900876092, espana@bitrialsupport.com

  • Hospital Universitario Marqués de Valdecilla

    Santander, 39008

    Boehringer Ingelheim, 900876092, espana@bitrialsupport.com

  • Complexo Hospitalario Universitario De Santiago

    Santiago, 15706

    Boehringer Ingelheim, 900876092, espana@bitrialsupport.com

  • Hospital Universitario Virgen De La Macarena

    Seville, 41009

    Boehringer Ingelheim, 900876092, espana@bitrialsupport.com

  • Hospital Virgen del Rocio

    Seville, 41013

    Boehringer Ingelheim, 900876092, espana@bitrialsupport.com

  • Hospital Universitari i Politècnic La Fe

    Valencia, 46026

    Boehringer Ingelheim, 900876092, espana@bitrialsupport.com

Other trials in Spain

United Kingdom21 sites

  • Heartlands Hospital

    Birmingham, B9 5SS

    Boehringer Ingelheim, 08000514022, unitedkingdom@bitrialsupport.com

  • Blackpool Victoria Hospital

    Blackpool, FY3 8NR

    Boehringer Ingelheim, 08000514022, unitedkingdom@bitrialsupport.com

  • Bradford Royal Infirmary

    Bradford, BD9 6RJ

    Boehringer Ingelheim, 08000514022, unitedkingdom@bitrialsupport.com

  • Velocity Clinical Research, Bristol

    Bristol, BS8 2RA

    Boehringer Ingelheim, 08000514022, unitedkingdom@bitrialsupport.com

  • Royal Papworth Hospital

    Cambridge, CB2 0AY

    Boehringer Ingelheim, 08000514022, unitedkingdom@bitrialsupport.com

  • University Hospital Llandough

    Cardiff, CF64 2XX

    Boehringer Ingelheim, 08000514022, unitedkingdom@bitrialsupport.com

  • Ninewells Hospital & Medical School

    Dundee, Scotland, DD1 9SY

    Boehringer Ingelheim, 08000514022, unitedkingdom@bitrialsupport.com

  • Royal Infirmary of Edinburgh

    Edinburgh, EH16 4SA

    Boehringer Ingelheim, 08000514022, unitedkingdom@bitrialsupport.com

  • Royal Hospital for Children and Young People

    Edinburgh, EH16 4TJ

    Boehringer Ingelheim, 08000514022, unitedkingdom@bitrialsupport.com

  • Western General Hospital

    Edinburgh, EH4 2XU

    Boehringer Ingelheim, 08000514022, unitedkingdom@bitrialsupport.com

  • Freeman Hospital

    High Heaton, NE7 7DN

    Boehringer Ingelheim, 08000514022, unitedkingdom@bitrialsupport.com

  • Royal Lancaster Infirmary

    Lancaster, LA1 4RP

    Boehringer Ingelheim, 08000514022, unitedkingdom@bitrialsupport.com

  • St James's University Hospital

    Leeds, LS9 7TF

    Boehringer Ingelheim, 08000514022, unitedkingdom@bitrialsupport.com

  • Liverpool Heart & Chest Hospital

    Liverpool, L14 3PE

    Boehringer Ingelheim, 08000514022, unitedkingdom@bitrialsupport.com

  • King's College Hospital

    London, SE5 9RS

    Boehringer Ingelheim, 08000514022, unitedkingdom@bitrialsupport.com

  • Royal Brompton Hospital

    London, SW3 6NP

    Boehringer Ingelheim, 08000514022, unitedkingdom@bitrialsupport.com

  • Craigavon Area Hospital

    Portadown, BT63 5QQ

    Boehringer Ingelheim, 08000514022, unitedkingdom@bitrialsupport.com

  • Northern General Hospital

    Sheffield, S5 7AU

    Boehringer Ingelheim, 08000514022, unitedkingdom@bitrialsupport.com

  • Southampton General Hospital

    Southampton, SO16 6YD

    Boehringer Ingelheim, 08000514022, unitedkingdom@bitrialsupport.com

  • Royal Stoke University Hospital

    Stoke-on-Trent, ST4 6QG

    Boehringer Ingelheim, 08000514022, unitedkingdom@bitrialsupport.com

  • Torbay Hospital

    Torquay, TQ2 7AA

    Boehringer Ingelheim, 08000514022, unitedkingdom@bitrialsupport.com

Other trials in United Kingdom

South Korea16 sites

  • Hallym University Sacred Heart Hospital

    Anyang, 14068

    Boehringer Ingelheim, 0808802084, namhan@bitrialsupport.com

  • Chungbuk National University Hospital

    Cheongju-si, 28644

    Boehringer Ingelheim, 0808802084, namhan@bitrialsupport.com

  • Yeongnam University Hospital

    Daegu, 42415

    Boehringer Ingelheim, 0808802084, namhan@bitrialsupport.com

  • Ulsan University Hospital

    Dong-gu Ulsan, 44033

    Boehringer Ingelheim, 0808802084, namhan@bitrialsupport.com

  • The Catholic University of Korea, Incheon St. Mary's Hospital

    Incheon, 21431

    Boehringer Ingelheim, 0808802084, namhan@bitrialsupport.com

  • The Catholic University of Korea, Eunpyeong St. Mary's Hospital

    Seoul, 03312

    Boehringer Ingelheim, 0808802084, namhan@bitrialsupport.com

  • Severance Hospital

    Seoul, 03722

    Boehringer Ingelheim, 0808802084, namhan@bitrialsupport.com

  • Konkuk University Medical Center

    Seoul, 05030

    Boehringer Ingelheim, 0808802084, namhan@bitrialsupport.com

  • Asan Medical Center

    Seoul, 05505

    Boehringer Ingelheim, 0808802084, namhan@bitrialsupport.com

  • Samsung Medical Center

    Seoul, 06351

    Boehringer Ingelheim, 0808802084, namhan@bitrialsupport.com

  • SMG-SNU Boramae Medical Center

    Seoul, 07071

    Boehringer Ingelheim, 0808802084, namhan@bitrialsupport.com

  • Korea University Guro Hospital

    Seoul, 08308

    Boehringer Ingelheim, 0808802084, namhan@bitrialsupport.com

  • The Catholic University of Korea, Seoul St.Mary's Hospital

    Seoul, 137-701

    Boehringer Ingelheim, 0808802084, namhan@bitrialsupport.com

  • Hallym University Kangnam Sacred Heart Hospital

    Seoul, 150-950

    Boehringer Ingelheim, 0808802084, namhan@bitrialsupport.com

  • Jeonbuk National University Hospital

    Seoul, 54907

    Boehringer Ingelheim, 0808802084, namhan@bitrialsupport.com

  • Yonsei University Wonju Severance Christian Hospital

    Wŏnju, 26426

    Boehringer Ingelheim, 0808802084, namhan@bitrialsupport.com

Other trials in South Korea

Italy15 sites

  • Policlinico S. Orsola-Malpighi

    Bologna, 40138

    Boehringer Ingelheim, 800977373, italia@bitrialsupport.com

  • Azienda Ospedaliero-Universitaria Policlinico G. Rodolico-San Marco Di Catania

    Catania, 95121

    Boehringer Ingelheim, 800977373, italia@bitrialsupport.com

  • Azienda Ospedaliera Meyer

    Florence, 50139

    Boehringer Ingelheim, 800977373, italia@bitrialsupport.com

  • Azienda Ospedaliera San Martino

    Genova, 16132

    Boehringer Ingelheim, 800977373, italia@bitrialsupport.com

  • Istituto G. Gaslini

    Genova, 16147

    Boehringer Ingelheim, 800977373, italia@bitrialsupport.com

  • A.O.U.Policlinico G.Martino

    Messina, 98124

    Boehringer Ingelheim, 800977373, italia@bitrialsupport.com

  • Fondazione IRCCS Ca'Granda-Ospedale Maggiore Policlinico

    Milan, 20122

    Boehringer Ingelheim, 800977373, italia@bitrialsupport.com

  • Azienda Socio Sanitaria Territoriale Di Monza

    Monza (MB), 20900

    Boehringer Ingelheim, 800977373, italia@bitrialsupport.com

  • Azienda Ospedaliera Universitaria "Federico II"

    Naples, 80131

    Boehringer Ingelheim, 800977373, italia@bitrialsupport.com

  • Azienda Ospedaliera Universitaria di Padova

    Padova, 35128

    Boehringer Ingelheim, 800977373, italia@bitrialsupport.com

  • Policlinico "Paolo Giaccone"

    Palermo, 90127

    Boehringer Ingelheim, 800977373, italia@bitrialsupport.com

  • Fondazione IRCCS Policlinico S. Matteo

    Pavia, 27100

    Boehringer Ingelheim, 800977373, italia@bitrialsupport.com

  • Ospedale Pediatrico Bambino Gesù

    Roma, 00165

    Boehringer Ingelheim, 800977373, italia@bitrialsupport.com

  • Istituto Clinico Humanitas

    Rozzano (MI), 20089

    Boehringer Ingelheim, 800977373, italia@bitrialsupport.com

  • Azienda Ospedaliera Universitaria Integrata Verona

    Verona, 37126

    Boehringer Ingelheim, 800977373, italia@bitrialsupport.com

Other trials in Italy

Bulgaria13 sites

  • Medical Center Zdrave-1 OOD

    Kozloduy, 3320

    Boehringer Ingelheim, 024903378, balgariya@bitrialsupport.com

  • Medical Center Hera - Montana Branch

    Montana, 3400

    Boehringer Ingelheim, 024903378, balgariya@bitrialsupport.com

  • MHAT Rahila Angelova AD

    Pernik, 2300

    Boehringer Ingelheim, 024903378, balgariya@bitrialsupport.com

  • DCC V Plovdiv St. Archbishop Luka EOOD

    Plovdiv, 4023

    Boehringer Ingelheim, 024903378, balgariya@bitrialsupport.com

  • Medical Center ReSpiro Ltd

    Razgrad, 7200

    Boehringer Ingelheim, 024903378, balgariya@bitrialsupport.com

  • Specialized Hospital For Active Treatment Of Pneumo-Phthisiatric Diseases Dr. Dimitar Gramatikov-Ruse

    Rousse, 7002

    Boehringer Ingelheim, 024903378, balgariya@bitrialsupport.com

  • Medical Center Hera EOOD

    Sofia, 1510

    Boehringer Ingelheim, 024903378, balgariya@bitrialsupport.com

  • University Medical Center "N. I. Pirogov"

    Sofia, 1606

    Boehringer Ingelheim, 024903378, balgariya@bitrialsupport.com

  • Diagnostics And Consultation Center Convex Ltd.

    Sofia, 1680

    Boehringer Ingelheim, 024903378, balgariya@bitrialsupport.com

  • Medical Center "Pulmovision"

    Sofia, 1756

    Boehringer Ingelheim, 024903378, balgariya@bitrialsupport.com

  • Medical Center Tara

    Veliko Tarnovo, 5000

    Boehringer Ingelheim, 024903378, balgariya@bitrialsupport.com

  • Medical Center "Sveti Ivan Rilski"

    Vidin, 3700

    Boehringer Ingelheim, 024903378, balgariya@bitrialsupport.com

  • Specialized Hospital For Active Treatment Of Pneumo-Physiatiric Diseases Vraca /Sbalpfz Vratsa EOOD

    Vratsa, 3001

    Boehringer Ingelheim, 024903378, balgariya@bitrialsupport.com

Other trials in Bulgaria

Argentina11 sites

  • Instituto de Medicina Respiratoria (IMeR)

    Alberdi Sur, X5003DCE

    Boehringer Ingelheim, 08002667801, argentina@bitrialsupport.com

  • Mautalen- Salud e Investigacion

    Buenos Aires, C1128AAF

    Boehringer Ingelheim, 08002667801, argentina@bitrialsupport.com

  • Fundacion NIBA Neurologia Infantil Buenos Aires

    CABA, 1182

    Boehringer Ingelheim, 08002667801, argentina@bitrialsupport.com

  • Centro de Investigacion Clinica Belgrano

    CABA, 1425

    Boehringer Ingelheim, 08002667801, argentina@bitrialsupport.com

  • Equipo Ciencia

    CABA, C1428BNF

    Boehringer Ingelheim, 08002667801, argentina@bitrialsupport.com

  • Hospital Aleman

    Capital Federal, C1118AAT

    Boehringer Ingelheim, 08002667801, argentina@bitrialsupport.com

  • APRILLUS-Asistencia e Investigacion

    Ciudad Autonoma Buenos Aires, C1046AAQ

    Boehringer Ingelheim, 08002667801, argentina@bitrialsupport.com

  • Instituto Ave Pulmo - Fundacion Enfisema

    Mar del Plata, 7600

    Boehringer Ingelheim, 08002667801, argentina@bitrialsupport.com

  • Centro Respiratorio de Quilmes

    Quilmes, B1878FNR

    Boehringer Ingelheim, 08002667801, argentina@bitrialsupport.com

  • Instituto de Especialidades de la Salud Rosario

    Rosario, 2000

    Boehringer Ingelheim, 08002667801, argentina@bitrialsupport.com

  • Ibamedica

    Santa Fe, 3000

    Boehringer Ingelheim, 08002667801, argentina@bitrialsupport.com

Other trials in Argentina

France11 sites

  • CHU Amiens-Picardie

    Amiens, 80054

    Boehringer Ingelheim, 0805102354, france@bitrialsupport.com

  • HOP Intercommunal

    Créteil, 94000

    Boehringer Ingelheim, 0805102354, france@bitrialsupport.com

  • INS Coeur Poumon

    Lille, 59037

    Boehringer Ingelheim, 0805102354, france@bitrialsupport.com

  • Hopital De La Croix-Rousse

    Lyon, 69004

    Boehringer Ingelheim, 0805102354, france@bitrialsupport.com

  • HOP Arnaud de Villeneuve

    Montpellier, 34295

    Boehringer Ingelheim, 0805102354, france@bitrialsupport.com

  • Hopital Pasteur

    Nice, 06001

    Boehringer Ingelheim, 0805102354, france@bitrialsupport.com

  • Hôpital Cochin

    Paris, 75014

    Boehringer Ingelheim, 0805102354, france@bitrialsupport.com

  • HOP Haut-Leveque

    Pessac, 33604

    Boehringer Ingelheim, 0805102354, france@bitrialsupport.com

  • HOP Pontchaillou

    Rennes, 35000

    Boehringer Ingelheim, 0805102354, france@bitrialsupport.com

  • HOP Nord Laennec

    Saint-Herblain, 44093

    Boehringer Ingelheim, 0805102354, france@bitrialsupport.com

  • Hôpital Larrey - CHU de Toulouse

    Tououse, 31059

    Boehringer Ingelheim, 0805102354, france@bitrialsupport.com

Other trials in France

Brazil7 sites

  • Serviços Medicos Respirar Sul Fluminense

    Barra Mansa, 27323240

    Boehringer Ingelheim, 08008919295, brasil@bitrialsupport.com

  • Faculdade de Medicina de Botucatu - UNESP

    Botucatu, 18618-687

    Boehringer Ingelheim, 08008919295, brasil@bitrialsupport.com

  • Chronos Pesquisa Clinica

    Brasília, 72145-450

    Boehringer Ingelheim, 08008919295, brasil@bitrialsupport.com

  • HC-UFG - Hospital das Clínicas da Universidade Federal de Goiás

    Goiânia, 74605-020

    Boehringer Ingelheim, 08008919295, brasil@bitrialsupport.com

  • Irmandade da Santa Casa de Misericórdia de Porto Alegre

    Porto Alegre, 90035-074

    Boehringer Ingelheim, 08008919295, brasil@bitrialsupport.com

  • Netspiro Clinica Medica Ltda - Respsono

    São Bernardo do Campo, 09750-420

    Boehringer Ingelheim, 08008919295, brasil@bitrialsupport.com

  • INCOR e Hospital das Clínicas da Universidade de São Paulo

    São Paulo, 05403-000

    Boehringer Ingelheim, 08008919295, brasil@bitrialsupport.com

Other trials in Brazil

Latvia7 sites

  • Daugavpils regionala slimnica SIA

    Daugavpils, 5401

    Boehringer Ingelheim, 80200224, latvia@bitrialsupport.com

  • Veselibas centru apvieniba AS

    Daugavpils, LV-5410

    Boehringer Ingelheim, 80200224, latvia@bitrialsupport.com

  • VCA Dubultu Medical center

    Jūrmala, 2015

    Boehringer Ingelheim, 80200224, latvia@bitrialsupport.com

  • Rigas 1. slimnica SIA

    Riga, 1001

    Boehringer Ingelheim, 80200224, latvia@bitrialsupport.com

  • Rigas Austrumu kliniska universitates slimnica SIA

    Riga, 2118

    Boehringer Ingelheim, 80200224, latvia@bitrialsupport.com

  • Pauls Stradins Clinical University Hospital

    Riga, LV-1002

    Boehringer Ingelheim, 80200224, latvia@bitrialsupport.com

  • Mediciniskas pecdiploma izglitibas instituts SIA

    Riga, LV-1011

    Boehringer Ingelheim, 80200224, latvia@bitrialsupport.com

Other trials in Latvia

Mexico7 sites

  • Centro de Investigacion Integral MEDIVEST S.C

    Chihuahua City, 31203

    Boehringer Ingelheim, 018000623749, mexico@bitrialsupport.com

  • Mediadvance Clinical S.A.P.I de C.V.

    Chihuahua City, 31203

    Boehringer Ingelheim, 018000623749, mexico@bitrialsupport.com

  • Centro de Investigacion Farmacologica del Bajío, S.C.

    León, 37160

    Boehringer Ingelheim, 018000623749, mexico@bitrialsupport.com

  • Soluciones terapeuticas medico quirurgicas S de RL de CV

    Mexico City, 03650

    Boehringer Ingelheim, 018000623749, mexico@bitrialsupport.com

  • Hospital Universitario Nuevo de Nuevo León - CEPREP

    Monterrey, Nuevo León, C.P. 64460

    Boehringer Ingelheim, 018000623749, mexico@bitrialsupport.com

  • Oaxaca Site Management Organization, S.C.

    Oaxaca City, 68000

    Boehringer Ingelheim, 018000623749, mexico@bitrialsupport.com

  • Clinical Research Institute S.C.

    Tlalnepantla, 54055

    Boehringer Ingelheim, 018000623749, mexico@bitrialsupport.com

Other trials in Mexico

Poland7 sites

  • Respiratory Medicine Centre, private prac., Bialystok

    Bialystok, 15-044

    Boehringer Ingelheim, 008001218830, polska@bitrialsupport.com

  • M2M Med. Badania Sp. z o.o.

    Chorzów, 41-500

    Boehringer Ingelheim, 008001218830, polska@bitrialsupport.com

  • Screenmed Sp. z o.o.

    Piaseczno, 05500

    Boehringer Ingelheim, 008001218830, polska@bitrialsupport.com

  • EMED, Center of Medical Services,Private Prac,Rzeszow

    Rzeszów, 35205

    Boehringer Ingelheim, 008001218830, polska@bitrialsupport.com

  • Przychodnia Alergologiczno-Pulmonologiczna Alergopneuma Sp. z o.o.

    Świdnik, 21040

    Boehringer Ingelheim, 008001218830, polska@bitrialsupport.com

  • Altamed Specjalistyczna Praktyka Lekarska Pawel Sliwinski

    Warsaw, 01-456

    Boehringer Ingelheim, 008001218830, polska@bitrialsupport.com

  • Centrum Badan Klinicznych Piotr Napora Lekarze sp.p.

    Wroclaw, 51-162

    Boehringer Ingelheim, 008001218830, polska@bitrialsupport.com

Other trials in Poland

Portugal7 sites

  • ULS da Região de Aveiro

    Aveiro, 3814-501

    Boehringer Ingelheim, 800856070, portugal@bitrialsupport.com

  • ULS de Braga, E.P.E

    Braga, 4710-243

    Boehringer Ingelheim, 800856070, portugal@bitrialsupport.com

  • CHUC - Centro Hospitalar e Universitario de Coimbra, EPE

    Coimbra, 3004-561

    Boehringer Ingelheim, 800856070, portugal@bitrialsupport.com

  • ULS do Alto Ave

    Guimarães, 4835-045

    Boehringer Ingelheim, 800856070, portugal@bitrialsupport.com

  • ULS da Região de Leiria, E.P.E.

    Leiria, 2410-197

    Boehringer Ingelheim, 800856070, portugal@bitrialsupport.com

  • ULS de Santa Maria, E.P.E

    Lisbon, 1649-035

    Boehringer Ingelheim, 800856070, portugal@bitrialsupport.com

  • Centro Hospitalar Universitário São João,EPE

    Porto, 4202-451

    Boehringer Ingelheim, 800856070, portugal@bitrialsupport.com

Other trials in Portugal

Denmark6 sites

  • Aalborg Sygehus Syd

    Aalborg, 9000

    Boehringer Ingelheim, 80711822, danmark@bitrialsupport.com

  • Aarhus University Hospital

    Aarhus N, 8200

    Boehringer Ingelheim, 80711822, danmark@bitrialsupport.com

  • Hvidovre Hospital

    Hvidovre, 2650

    Boehringer Ingelheim, 80711822, danmark@bitrialsupport.com

  • Copenhagen University Hospital, Rigshospitalet

    Københagen Ø, 2100

    Boehringer Ingelheim, 80711822, danmark@bitrialsupport.com

  • Odense University Hospital

    Odense C, 5000

    Boehringer Ingelheim, 80711822, danmark@bitrialsupport.com

  • Vejle University Hospital

    Vejle, 7100

    Boehringer Ingelheim, 80711822, danmark@bitrialsupport.com

Other trials in Denmark

Israel6 sites

  • Soroka Univ. Medical Center

    Beersheba, 8410101

    Boehringer Ingelheim, 1809388162, israel@bitrialsupport.com

  • Lady Davis Carmel Medical Center

    Haifa, 3436212

    Boehringer Ingelheim, 1809388162, israel@bitrialsupport.com

  • Hadassah Medical Center, Ein-Karem

    Jerusalem, 9112001

    Boehringer Ingelheim, 1809388162, israel@bitrialsupport.com

  • Hadassah Medical Center, Ein-Karem

    Jerusalem, 9765422

    Boehringer Ingelheim, 1809388162, israel@bitrialsupport.com

  • Rabin Medical Center Beilinson

    Petah Tikva, 4941492

    Boehringer Ingelheim, 1809388162, israel@bitrialsupport.com

  • Sourasky Medical Center

    Tel Aviv, 6093246

    Boehringer Ingelheim, 1809388162, israel@bitrialsupport.com

Other trials in Israel

Netherlands6 sites

  • Noordwest Ziekenhuisgroep

    Alkmaar, 1815 JD

    Boehringer Ingelheim, 08000204613, nederland@bitrialsupport.com

  • Amsterdam UMC Locatie VUMC

    Amsterdam, 1081HV

    Boehringer Ingelheim, 08000204613, nederland@bitrialsupport.com

  • Erasmus Medisch Centrum

    Rotterdam, 3015 GD

    Boehringer Ingelheim, 08000204613, nederland@bitrialsupport.com

  • Haga Ziekenhuis

    The Hague, 2545 AA

    Boehringer Ingelheim, 08000204613, nederland@bitrialsupport.com

  • UMC Utrecht

    Utrecht, 3584 CX

    Boehringer Ingelheim, 08000204613, nederland@bitrialsupport.com

  • Gelre Ziekenhuis Zutphen

    Zutphen, 7207 AE

    Boehringer Ingelheim, 08000204613, nederland@bitrialsupport.com

Other trials in Netherlands

Canada5 sites

  • BLC Clinical Research

    Burlington, Ontario, L7N 3V2

    Boehringer Ingelheim, 18336022346, canada@bitrialsupport.com

  • University of Calgary

    Calgary, Alberta, T2N 4Z6

    Boehringer Ingelheim, 18336022346, canada@bitrialsupport.com

  • Centre Hospitalier de l'Universite de Montreal (CHUM)

    Montreal, Quebec, H2X 0A9

    Boehringer Ingelheim, 18336022346, canada@bitrialsupport.com

  • Institut Universitaire de Cardiologie et de Pneumologie de Quebec (IUCPQ)

    Québec, G1V 4G5

    Boehringer Ingelheim, 18336022346, canada@bitrialsupport.com

  • St. Paul's Hospital (Vancouver)

    Vancouver, British Columbia, V6Z 1Y6

    Boehringer Ingelheim, 18336022346, canada@bitrialsupport.com

Other trials in Canada

Philippines5 sites

  • Iloilo Doctors Hospital

    Iloilo City, 5000

    Boehringer Ingelheim, 180084748502, pilipinas@bitrialsupport.com

  • West Visayas State University Medical Center

    Iloilo City, 5000

    Boehringer Ingelheim, 180084748502, pilipinas@bitrialsupport.com

  • Health Cube Medical Clinics

    Mandaluyong, 1552

    Boehringer Ingelheim, 180084748502, pilipinas@bitrialsupport.com

  • Quirino Memorial Medical Center

    Quezon City, 1109

    Boehringer Ingelheim, 180084748502, pilipinas@bitrialsupport.com

  • Philippine General Hospital

    Taft, Manila, 1000

    Boehringer Ingelheim, 180084748502, pilipinas@bitrialsupport.com

Other trials in Philippines

Belgium4 sites

  • Cliniques Universitaires Saint-Luc

    Brussels, 1200

    Boehringer Ingelheim, 080049616, belgique@bitrialsupport.com

  • Universitair Ziekenhuis Gent

    Ghent, 9000

    Boehringer Ingelheim, 080049616, belgique@bitrialsupport.com

  • UZ Leuven

    Leuven, 3000

    Boehringer Ingelheim, 080049616, belgique@bitrialsupport.com

  • Vitaz - Campus Sint-Niklaas

    Sint-Niklaas, 9100

    Boehringer Ingelheim, 080049616, belgique@bitrialsupport.com

Other trials in Belgium

Finland4 sites

  • Helsinki University Hospital

    Helsinki, 00290 HUS

    Boehringer Ingelheim, 0800918118, suomi@bitrialsupport.com

  • Northern Clinical Trial Coordinators

    Oulu, 90150

    Boehringer Ingelheim, 0800918118, suomi@bitrialsupport.com

  • Tampere University Hospital

    Tampere, 33520

    Boehringer Ingelheim, 0800918118, suomi@bitrialsupport.com

  • Turku University Hospital / TYKS

    Turku, 20521

    Boehringer Ingelheim, 0800918118, suomi@bitrialsupport.com

Other trials in Finland

Malaysia4 sites

  • Hospital Sultan Idris Shah Serdang

    Kajang, 43000

    Boehringer Ingelheim, 1800814353, malaysia@bitrialsupport.com

  • Hospital Raja Perempuan Zainab II

    Kelantan, 15586

    Boehringer Ingelheim, 1800814353, malaysia@bitrialsupport.com

  • University Malaya Medical Centre

    Kuala Lumpur, 59100

    Boehringer Ingelheim, 1800814353, malaysia@bitrialsupport.com

  • Sarawak General Hospital

    Kuching, 93586

    Boehringer Ingelheim, 1800814353, malaysia@bitrialsupport.com

Other trials in Malaysia

Romania4 sites

  • Institutul De Pneumoftiziologie Marius Nasta

    Bucharest, 050159

    Boehringer Ingelheim, 0800895209, romania@bitrialsupport.com

  • SC Medlife S.A

    Cluj-Napoca, 400003

    Boehringer Ingelheim, 0800895209, romania@bitrialsupport.com

  • Spitalul Clinic De Pneumoftiziologie Leon Daniello

    Cluj-Napoca, 400371

    Boehringer Ingelheim, 0800895209, romania@bitrialsupport.com

  • Clinical Hospital Of Infectious Diseases And Pneumophysiology Dr.Victor Babes Timisoara

    Timișoara, 300310

    Boehringer Ingelheim, 0800895209, romania@bitrialsupport.com

Other trials in Romania

Taiwan4 sites

  • Kaohsiung Medical University Chung-Ho Memorial Hospital

    Kaohsiung City, 807

    Boehringer Ingelheim, 0809092098, taiwan@bitrialsupport.com

  • Kaohsiung Chang Gung Memorial Hospital

    Kaohsiung City, 83301

    Boehringer Ingelheim, 0809092098, taiwan@bitrialsupport.com

  • Taichung Veterans General Hospital

    Taichung, 40705

    Boehringer Ingelheim, 0809092098, taiwan@bitrialsupport.com

  • Chang Gung Memorial Hospital, Linkou

    Taoyuan City, 333

    Boehringer Ingelheim, 0809092098, taiwan@bitrialsupport.com

Other trials in Taiwan

Hungary3 sites

  • Semmelweis University

    Budapest, 1083

    Boehringer Ingelheim, 680017725, magyarorszag@bitrialsupport.com

  • BKS Research Ltd

    Hatvan, 3000

    Boehringer Ingelheim, 680017725, magyarorszag@bitrialsupport.com

  • Da Vinci Private Clinic

    Pécs

    Boehringer Ingelheim, 680017725, magyarorszag@bitrialsupport.com

Other trials in Hungary

Lithuania3 sites

  • Hospital of Lithuanian University of Health Sciences Kauno Klinikos

    Kaunas, 50161

    Boehringer Ingelheim, 080080099, lithuania@bitrialsupport.com

  • Republic Klaipeda Hospital

    Klaipėda, 92231

    Boehringer Ingelheim, 080080099, lithuania@bitrialsupport.com

  • Vilnius University Hospital, Santariskiu

    Vilnius, 08406

    Boehringer Ingelheim, 080080099, lithuania@bitrialsupport.com

Other trials in Lithuania

Singapore3 sites

  • Singapore General Hospital

    Singapore, 169608

    Boehringer Ingelheim, 8001207344, singapore@bitrialsupport.com

  • Tan Tock Seng Hospital

    Singapore, 308433

    Boehringer Ingelheim, 8001207344, singapore@bitrialsupport.com

  • Changi General Hospital

    Singapore, 529905

    Boehringer Ingelheim, 8001207344, singapore@bitrialsupport.com

Other trials in Singapore

Sweden3 sites

  • Universitetssjukhuset, Örebro

    Örebro, 703 82

    Boehringer Ingelheim, 0200880001, sverige@bitrialsupport.com

  • Karolinska University Hospital

    Stockholm, SE-171 64

    Boehringer Ingelheim, 0200880001, sverige@bitrialsupport.com

  • CTC Clinical Trial Consultants AB

    Uppsala, 752 37

    Boehringer Ingelheim, 0200880001, sverige@bitrialsupport.com

Other trials in Sweden

Austria2 sites

  • Medical University of Graz

    Graz, 8036

    Boehringer Ingelheim, 0800017900, oesterreich@bitrialsupport.com

  • Medical University of Innsbruck

    Innsbruck, 6020

    Boehringer Ingelheim, 0800017900, oesterreich@bitrialsupport.com

Other trials in Austria

Chile2 sites

  • Centro de Estudios Clinicos CEC

    Santiago, 7750000

    Boehringer Ingelheim, 800392345, chile@bitrialsupport.com

  • Centro de Investigacion del Maule

    Talca, 3465586

    Boehringer Ingelheim, 800392345, chile@bitrialsupport.com

Other trials in Chile

Czechia2 sites

  • MediTrial s.r.o.

    Jindřichův Hradec, 377 01

    Boehringer Ingelheim, 00441144040048, support@bitrialsupport.com

  • The First Pulmonary Private Practice

    Prague, 19000

    Boehringer Ingelheim, 00441144040048, support@bitrialsupport.com

Other trials in Czechia

Hong Kong2 sites

  • Prince Of Wales Hospital

    Hong Kong, 999077

    Boehringer Ingelheim, 800965365, hongkong@bitrialsupport.com

  • Queen Mary Hospital

    Hong Kong, 999077

    Boehringer Ingelheim, 800965365, hongkong@bitrialsupport.com

Other trials in Hong Kong

Ireland2 sites

  • Cork University Hospital

    Cork, T12 DC4A

    Boehringer Ingelheim, 08000514022, unitedkingdom@bitrialsupport.com

  • Connolly Hospital Blanchardstown

    Dublin, D15 X40D

    Boehringer Ingelheim, 08000514022, unitedkingdom@bitrialsupport.com

Other trials in Ireland

Kazakhstan2 sites

  • Multidisciplinary City Hospital №1 of the Akimat of Astana

    Astana, 010000

    Boehringer Ingelheim, 88000808264, kazakhstan@bitrialsupport.com

  • Regional Clinical Hospital of the Health Department of the Karaganda Region

    Karaganda, 100019

    Boehringer Ingelheim, 88000808264, kazakhstan@bitrialsupport.com

Other trials in Kazakhstan

Slovakia2 sites

  • Univerzitna Nemocnica Martin

    Martin, 036 01

    Boehringer Ingelheim, 0800002662, slovensko@bitrialsupport.com

  • Plucna ambulancia Hrebenar s.r.o.

    Spišská Nová Ves, 05201

    Boehringer Ingelheim, 0800002662, slovensko@bitrialsupport.com

Other trials in Slovakia

Switzerland2 sites

  • Universitätsspital Basel

    Basel, 4031

    Boehringer Ingelheim, 0800005900, suisse@bitrialsupport.com

  • University Hospital of Lausanne

    Lausanne

    Boehringer Ingelheim, 0800005900, suisse@bitrialsupport.com

Other trials in Switzerland

Thailand2 sites

  • Siriraj Hospital

    Bangkok, 10700

    Boehringer Ingelheim, 1800019059, thai@bitrialsupport.com

  • Ramathibodi Hospital

    Ratchathewi, 10400

    Boehringer Ingelheim, 1800019059, thai@bitrialsupport.com

Other trials in Thailand

About this study

Official title: An Open-label, Roll-over Study Evaluating the Long-term Safety and Efficacy of an Oral Dose of Verducatib q.d. in Patients With Bronchiectasis (AIRTIVITY®-ON)

This study is for adults and adolescents who are at least 12 years old and have bronchiectasis. People can participate if they completed a previous study with the study medicine called verducatib. The purpose of this study is to find out how well verducatib is tolerated when people with bronchiectasis take it for a long time. The study also looks at breathing problems, how often lung flare-ups happen, and how quickly lung function changes.

This is a roll-over study for participants who completed a previous study with verducatib: AIRTIVITY® (1397-0014) or CLAIRLEAF® (1397-0017). All participants receive verducatib. Participants take verducatib as tablets once a day at home. They may continue their usual treatment for bronchiectasis during the study.

Participants can stay in the study for up to 1 year and 9 months. Treatment with verducatib can continue for up to 1 year and 6 months. About 6 study visits are done at the study site and about 4 are done by phone. At all visits, the doctors check participants' health and collect information on any health problems that occur during the study. The doctors also look at lung flare-ups and measure lung function over time.

Conditions
Bronchiectasis
Being tested
verducatib
Medical subject headings
Bronchiectasis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • verducatibDrug

    Also called BI 1291583

    verducatib

Study groups in NCT07915219
Study groupRoleWhat they receive
Participants with bronchiectasis rolling over from parent trialsExperimentalParticipants with bronchiectasis who completed parent trials AIRTIVITY® (1397-0014) or CLAIRLEAF® (1397-0017) and did not prematurely discontinue the trial drug.
Receives: Drug: verducatib

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Occurrence of treatment-emergent adverse events (TEAEs) over the course of this trial

    Measured: up to 78 weeks

Secondary outcomes (7)

  1. Annualised rate of pulmonary exacerbations (number of events per person-time) up to Week 78

    Measured: up to 78 weeks

  2. Time to first pulmonary exacerbation from first drug administration up to Week 78

    Measured: up to 78 weeks

  3. Absolute change from baseline in post-bronchodilator forced expiratory volume in the first second (FEV1) %pred up to Week 78

    Measured: at baseline, at week 78

  4. Absolute change from baseline in post-bronchodilator forced vital capacity (FVC) %pred up to Week 78

    Measured: at baseline, at week 78

  5. High-resolution computed tomography (HRCT) substudy: Change from baseline (52-week HRCT from the parent trial) in total number of mucus plugs at Week 78

    Measured: at baseline, at week 78

  6. HRCT substudy: Change from baseline (52-week HRCT from the parent trial) in volume of mucus plugs at Week 78

    Measured: at baseline, at week 78

  7. HRCT substudy: Change from baseline (52-week HRCT from the parent trial) in bronchial wall area over bronchial outer area (Bwa/Boa) at Week 78

    Measured: at baseline, at week 78

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Nov 2026
  2. Study start11 Jan 2027 (estimated)
  3. Primary completion31 Jul 2029 (estimated)
  4. Study completion10 Sep 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 3
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
1,500 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07915219
Sponsor's protocol ID
1397-0018
Other IDs
U1111-1341-3104, 2026-527086-30-00
Status last verified
Oct 2026
First submitted
30 Oct 2026
Last updated
4 Nov 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
Yes
FDA-regulated device
No
Individual data sharing
Yes: Once the criteria in section "Time Frame" are fulfilled, researchers can use the following link https://www.clinicalstudies.boehringer-ingelheim.com/msw/datasharing to request access to the clinical study documents regarding this study, and upon a signed "Document Sharing Agreement". Furthermore, researchers can request access to the clinical study data, for this and other listed studies, after the submission of a research proposal and according to the terms outlined on the website.

Questions about this trial

What is this clinical trial studying?

A Phase 3 study testing verducatib in people with Bronchiectasis, run by Boehringer Ingelheim at 383 sites in 39 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 4 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 383 sites in United States, China, Japan, Germany, Spain and 34 more countries. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Boehringer Ingelheim (18002430127, clintriage.rdg@boehringer-ingelheim.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Occurrence of treatment-emergent adverse events (TEAEs) over the course of this trial (time frame: up to 78 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07915219.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Nov 2026.

AzTrials uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in